33
Participants
Start Date
January 1, 2022
Primary Completion Date
March 4, 2022
Study Completion Date
March 4, 2022
SUNY Upstate Medical University, Syracuse
Meharry Medical College/Meharry Medical Center, Nashville
University of Nebraska Medical Center, Omaha
Clinical Trials of Texas, LLC, San Antonio
Pan American Clinical Research LLC, Brownsville
Beth Israel Deaconess Medical Center, Boston
Clinisalud, Envigado
Bluecare Salud SAS, Bogotá
Servimed SAS, Bucaramanga
University Hospital Center of Guadeloupe, Les Abymes
Andhra Medical College, Visakhapatnam
Unity Hospital, Surat
GMERS Medical College & Hospital, Vadodara
Government Medical College & Hospital, Aurangabad
Govt. Medical College, Nagpur
Grant Medical Foundation Ruby Hall Clinic, Pune
Peerless Hospitex Hospital, Kolkata
Icaro Investigaciones en Medicina SA de CV, Chihuahua City
Worthwhile Clinical Trials, Benoni
REIMED Wilhase Practice, Boksburg
Clinresco Centres, Kempton Park
Larisha Pillay-Ramaya, Pretoria
Muhammed Ameen Fulat, Pretoria
Johan Geldenhuys, Vereeniging
DR P J Sebastian Clinical Research Centre, Durban
Synapta Clinical Research Centre, Durban
Clinical Research Institute of South Africa (CRISA), KwaDukuza
Aurum Klerksdorp CRS, Klerksdorp
The Aurum Institute, Rustenburg Clinical Research Site, Rustenburg
Langeberg Clinical Trials, Cape Town
Task Applied Science, Cape Town
CAIMED Center at the Ponce School of Medicine, Ponce
Lead Sponsor
Biomedical Advanced Research and Development Authority
FED
Pharm-Olam, LLC
INDUSTRY